Free Cash Flow Chart

View Free Cash Flow for TARS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 56.00M
March 31, 2026 -31.54M
December 31, 2025 -22.31M
September 30, 2025 -62.54M
June 30, 2025 -87.82M
March 31, 2025 -72.87M
December 31, 2024 -89.59M
September 30, 2024 -101.68M
June 30, 2024 -129.48M
March 31, 2024 -138.65M
December 31, 2023 -123.00M
September 30, 2023 -94.66M
Date Value
June 30, 2023 -76.63M
March 31, 2023 -56.40M
December 31, 2022 -49.54M
September 30, 2022 -50.93M
June 30, 2022 -25.23M
March 31, 2022 -0.316M
December 31, 2021 3.162M
September 30, 2021 5.594M
June 30, 2021 -8.104M
March 31, 2021 -31.53M
December 31, 2020 -21.59M
September 30, 2020 -12.46M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Veradermics, Inc. --
ANI Pharmaceuticals, Inc. 167.52M
Corcept Therapeutics, Inc. 106.92M
Veru, Inc. -26.04M
Johnson & Johnson 22.61B